Related Experiment Video
Updated: Mar 2, 2026

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
Natural products modulating the hERG channel: heartaches and hope
Jadel M Kratz1, Ulrike Grienke, Olaf Scheel
1Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. judith.rollinger@univie.ac.at.
Insights
The human Ether-à-go-go Related Gene (hERG) channel is crucial for heart function. This review compiles data on natural compounds that block the hERG channel, impacting cardiac safety and drug development.
Area of Science:
- Cardiovascular Pharmacology
- Ion Channel Physiology
- Natural Product Chemistry
Background:
- The human Ether-à-go-go Related Gene (hERG) channel is vital for cardiac electrical activity, regulating repolarization.
- hERG channel dysfunction, due to gene mutations or small molecule blockage, increases the risk of fatal cardiac arrhythmias.
- hERG channel blockers have led to drug withdrawals, highlighting its importance as an antitarget in drug discovery.
Purpose of the Study:
- To critically compile hERG channel data for natural products and extracts from 1996-2016.
- To provide a molecular understanding of hERG channel functions and their clinical relevance.
- To explore strategies for identifying hERG channel blockers from natural sources and their implications for cardiac safety.
Main Methods:
- Comprehensive literature review of studies published between 1996 and 2016.
- Compilation and critical analysis of hERG channel blocking data for isolated natural products and botanical extracts.
- Assessment of the translational potential of in vitro/in vivo findings to human cardiotoxicity.
Main Results:
- Identified a significant body of research on hERG channel interactions with natural compounds over two decades.
- Highlighted the lack of routine assessment for hERG channel blocking profiles of commonly consumed botanicals.
- Detailed the known cardiotoxic risks associated with hERG channel modulation by natural products.
Conclusions:
- Natural compounds in dietary supplements and herbal products can interact with the hERG channel, posing potential cardiac risks.
- There is a need for systematic evaluation of hERG channel activity in phytopharmaceuticals and dietary supplements.
- Future research should focus on developing cardiac safety guidelines and exploring novel therapeutic applications of hERG channel modulation.
Abstract:
Covering: 1996-December 2016The human Ether-à-go-go Related Gene (hERG) channel is a voltage-gated potassium channel playing an essential role in the normal electrical activity in the heart. It is involved in the repolarization and termination of action potentials in excitable cardiac cells. Mutations in the hERG gene and hERG channel blockage by small molecules are associated with increased risk of fatal arrhythmias. Several drugs have been withdrawn from the market due to hERG channel-related cardiotoxicity. Moreover, as a result of its notorious ligand promiscuity, this ion channel has emerged as an important antitarget in early drug discovery and development. Surprisingly, the hERG channel blocking profile of natural compounds present in frequently consumed botanicals (i.e. dietary supplements, spices, and herbal medicinal products) is not routinely assessed. This comprehensive review will address these issues and provide a critical compilation of hERG channel data for isolated natural products and extracts over the past two decades (1996-2016). In addition, the review will provide (i) a solid basis for the molecular understanding of the physiological functions of the hERG channel, (ii) the translational potential of in vitro/in vivo results to cardiotoxicity in humans, (iii) approaches for the identification of hERG channel blockers from natural sources, (iv) future perspectives for cardiac safety guidelines and their applications within phytopharmaceuticals and dietary supplements, and (v) novel applications of hERG channel modulation (e.g. as a drug target).
More Related Videos
Related Concept Videos
G-Protein Gated Ion Channels
Sensory...
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: β-Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

